Chemoembolization: Difference between revisions
Jump to navigation
Jump to search
imported>Robert Badgett |
imported>Daniel Mietchen m (+subpages) |
||
| (One intermediate revision by one other user not shown) | |||
| Line 1: | Line 1: | ||
{{subpages}} | |||
In [[medicine]], '''chemoembolization''', also called '''transcatheter arterial chemoembolization''' ('''TACE'''), is "administration of antineoplastic agents together with an embolizing vehicle. This allows slow release of the agent as well as obstruction of the blood supply to the neoplasm."<ref>{{MeSH}}</ref> | In [[medicine]], '''chemoembolization''', also called '''transcatheter arterial chemoembolization''' ('''TACE'''), is "administration of antineoplastic agents together with an embolizing vehicle. This allows slow release of the agent as well as obstruction of the blood supply to the neoplasm."<ref>{{MeSH}}</ref> | ||
==Efficacy== | ==Efficacy== | ||
Chemoembolization may improve survival of patients with hepatocellular carcinoma.<ref>PMID | Chemoembolization may improve survival of patients with hepatocellular carcinoma.<ref>PMID 11981766</ref> | ||
==Adverse effects== | ==Adverse effects== | ||
| Line 8: | Line 10: | ||
More serious adverse effects include: | More serious adverse effects include: | ||
* Cerebral lipiodol embolism (CLE)<ref>PMID | * Cerebral lipiodol embolism (CLE)<ref>PMID 17171304</ref><ref>PMID 16227000 </ref><ref>PMID 16163042</ref><ref>PMID 18720550 </ref> | ||
* Pulmonary embolism<ref>PMID | * Pulmonary embolism<ref>PMID 16274465</ref><ref>PMID 18720550 </ref> | ||
* Ruptured [[hepatocellular carcinoma]]<ref>PMID | * Ruptured [[hepatocellular carcinoma]]<ref>PMID 17287166</ref> | ||
==References== | ==References== | ||
<references/> | <references/> | ||
Latest revision as of 10:49, 4 June 2009
In medicine, chemoembolization, also called transcatheter arterial chemoembolization (TACE), is "administration of antineoplastic agents together with an embolizing vehicle. This allows slow release of the agent as well as obstruction of the blood supply to the neoplasm."[1]
Efficacy
Chemoembolization may improve survival of patients with hepatocellular carcinoma.[2]
Adverse effects
Post-embolization syndrome is a common adverse effect and is pain, nausea, and fever.[3]
More serious adverse effects include:
- Cerebral lipiodol embolism (CLE)[4][5][6][7]
- Pulmonary embolism[8][9]
- Ruptured hepatocellular carcinoma[10]
References
- ↑ Anonymous (2024), Chemoembolization (English). Medical Subject Headings. U.S. National Library of Medicine.
- ↑ PMID 11981766
- ↑ Chemoembolization — Interventional Radiology Clinic — UW Radiology.
- ↑ PMID 17171304
- ↑ PMID 16227000
- ↑ PMID 16163042
- ↑ PMID 18720550
- ↑ PMID 16274465
- ↑ PMID 18720550
- ↑ PMID 17287166